Multaq and Severe Liver Damage
Multaq is a medication prescribed to help patients with an abnormal heartbeat.
Its manufacturer, Sanofi-Aventis, reveals there have been at least 150
cases reported of liver damage to patients who took this anti-arrhythmic
drug. Two of the Multaq liver damage cases were severe enough to require
The FDA will begin to require Multaq's drug label to warn of the risk
of liver injury. The
FDA issued a Drug Safety Alert for Multaq regarding the severe liver injuries that may happen with using Multaq.
According to the FDA, "Dronedarone was approved with a Risk Evaluation
and Mitigation Strategy (REMS) with a goal of preventing its use in patients
with severe heart failure or who have recently been in the hospital for
heart failure. In a study of patients with these conditions, patients
given dronedarone had a greater than two-fold increase in risk of death."
See the announcement from the FDA
Information about the potential risk of liver injury from dronedarone is
being added to the WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS sections
of the dronedarone labels. Sanofi-Aventis marketed Multaq as a better
alternative to amiodarone, a medication associated with serious liver
and lung injury in its users. Now the question is whether Multaq actually
was safer than the cheaper, older drug it was meant to replace.
Danger of Liver Damage
Sanofi-Aventis recently admitted to the federal Food and Drug Administration
(the FDA) that the company received many reports of liver injury and liver
failure in individuals taking Multaq.
Signs of liver damage from Multaq may include:
- Loss of appetite
- Pain or discomfort in the upper right area of the stomach
- Yellowing (known as jaundice) of the skin or whites of the eyes
- Darker urine
Other less serious side effects that have been reported with Multaq include
rashes, stomach pain, slower heartbeat, breathing difficulty and rapid
Anyone who believes they are showing signs of liver damage related to Multaq
should contact their doctor immediately. It is critical that no prescription
be discontinued without consulting with a doctor to discuss the risks involved.
Did you take Multaq and suffer a liver injury? Call our trial lawyers now.
Multaq was first sold in the United States in July 2009 to treat abnormal
heartbeats. Close to 150,000 people have taken this drug and if you are
one of them and you have suffered liver damage, our attorneys at Fibich,
Leebron, Copeland & Briggs are available to discuss your injury and
the possibility that you may be owed money damages from the maker of Multaq.
If you choose to have a legal evaluation of your use of Multaq and your
health problems, we can provide a
free confidential consultation. Our attorneys are familiar with the issues concerning the Multaq cases
and the kind of resources you may require during your recovery.
Our team of professionals can be reached when you
at (713) 489-6566.